Moss Adams Wealth Advisors LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Moss Adams Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,320 shares of the healthcare conglomerate’s stock after buying an additional 394 shares during the quarter. Moss Adams Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $2,526,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the 3rd quarter worth about $27,000. Macroview Investment Management LLC lifted its holdings in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter valued at $31,000. Finally, Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.6 %

Shares of UNH stock opened at $569.61 on Friday. The firm has a market capitalization of $525.99 billion, a PE ratio of 37.77, a P/E/G ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The business’s fifty day moving average price is $584.42 and its 200 day moving average price is $533.63. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.56 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Stephens reduced their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday. UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday. Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Robert W. Baird upped their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.